PlumX Metrics
Embed PlumX Metrics

Development of the optimal scheme for the synthesis of the dipeptide TSPO ligand, N-phenylpropionyl-L-tryptophanyl-L-leucine amide (GD-102), a potential anxiolytic drug

Pharmacokinetics and Pharmacodynamics, ISSN: 2587-7836, Issue: 4, Page: 83-94
2024
  • 0
    Citations
  • 0
    Usage
  • 0
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Mentions
    1
    • News Mentions
      1
      • 1

Most Recent News

Federal Research Center Researcher Provides New Data on Pharmacokinetics and Pharmacodynamics [Development of the optimal scheme for the synthesis of the dipeptide TSPO ligand, N-phenylpropionyl-L-tryptophanyl-L-leucine amide (GD-102), a ...]

2024 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Current study results on pharmacokinetics and pharmacodynamics have been

Article Description

Pharmacokinetics and Pharmacodynamics

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know